Proteomics and severe acute respiratory syndrome (SARS): Emerging technology meets emerging pathogen

Clinical Chemistry

Volumn 51, Issue 1, 2005, Pages 6-7

  Mazzulli, Tony ^a   Low, Donald E ^a,b   Poutanen, Susan M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

DISEASE SEVERITY; EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MASS SPECTROMETRY; NONHUMAN; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; VIRUS DETECTION; VIRUS INFECTION;

BLOOD SPECIMEN COLLECTION; HUMANS; PROTEOME; SARS VIRUS; SERUM AMYLOID A PROTEIN; SEVERE ACUTE RESPIRATORY SYNDROME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TIME FACTORS; VIRAL PROTEINS;

SARS CORONAVIRUS;

EID: 11144348657     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.041574     Document Type: Editorial

References (9)

1. Rainer TH, Cameron PA, Smit D, Ong KL, Hung AN, Nin DC, et al. Evaluation of WHO criteria for identifying patients with severe acute respiratory syndrome out of hospital: prospective observational study. BMJ 2003;326:1354-8.
2. Schrag SJ, Brooks JT, van Beneden C, Parashar UD, Griffin PM, Anderson LJ, et al. SARS surveillance during emergency public health response, United States, March-July 2003. Emerg Infect Dis 2004;10:185-94.
3. Tambyah PA, Singh KS, Habib AG. SARS: understanding the coronavirus: accuracy of WHO criteria was similar in a "non-SARS" hospital in Singapore. BMJ 2003;327:620.
4. Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003;361:1767-72.
5. Lau SK, Woo PC, Wong BH, Tsoi HW, Woo GK, Poon RW, et al. Detection of severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in SARS patients by enzyme-linked immunosorbent assay. J Clin Microbiol 2004;42:2884-9.
6. Tang P, Louie M, Richardson SE, Smieja M, Simor AE, Jamieson F, et al. Interpretation of diagnostic laboratory tests for severe acute respiratory syndrome: the Toronto experience. CMAJ 2004;170:47-54.
7. Kang X, Xu Y, Wu X, Liang Y, Wang C, Guo J, et al. Proteomic fingerprints for potential application to early diagnosis of severe acute respiratory syndrome. Clin Chem 2004;51.
8. Yip TTC, Chan JWM, Cho WCS, Yip T-T, Wang Z, Kwan T-L, et al; QEH/GVU/Ciphergen SARS Proteomics Study Group. Protein chip array profiling analysis in patients with severe acute respiratory syndrome identified serum amyloid A protein as a biomarker potentially useful in monitoring the extent of pneumonia. Clin Chem 2004;51:47-55.
9. Picard FJ, Bergeron MG. Rapid molecular theranostics in infectious diseases. Drug Discov Today 2002;7:1092-101.